Honliv Healthcare Management Group Company Limited

HKEX:9906.HK

2.3 (HKD) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 207.589207.589195.03195.03185.234185.234176.524176.524187.371187.371160.217160.217143.202143.202139.695139.695122.327122.327129.988129.988135.567135.567
Cost of Revenue 171.779171.779157.583157.583150.259150.259149.112149.112143.36143.36126.396126.396109.37109.37101.781101.78191.44591.44589.97689.97690.50190.501
Gross Profit 35.81135.81137.44737.44734.97534.97527.41227.41244.01244.01233.82133.82133.83333.83337.91437.91430.88230.88240.01240.01245.06645.066
Gross Profit Ratio 0.1730.1730.1920.1920.1890.1890.1550.1550.2350.2350.2110.2110.2360.2360.2710.2710.2520.2520.3080.3080.3320.332
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 19.34519.34517.51117.51118.46618.46618.7418.7417.60317.60317.93617.93616.3116.3117.33917.33918.26118.26120.08220.08216.66916.669
Selling & Marketing Expenses 0.160.168.2050.33822.538-0.33818.792-2.0163.3273.3270.070.07002.3052.305000.30.300
SG&A 19.50519.50525.71625.71618.12818.12816.72416.72420.9320.9318.00618.00616.3116.3119.64419.64418.26118.26120.38220.38216.66916.669
Other Expenses 0.390.39-0.150000000000000000000
Operating Expenses 19.89419.89425.56625.73617.54617.54614.814.820.7620.7619.19519.19516.66816.66825.56625.56618.16118.16122.99322.99316.57616.576
Operating Income 15.91715.91711.88111.8916.84216.8429.8669.86623.1523.1515.55615.55617.75517.75518.26518.26512.72112.72119.7819.7828.49128.491
Operating Income Ratio 0.0770.0770.0610.0610.0910.0910.0560.0560.1240.1240.0970.0970.1240.1240.1310.1310.1040.1040.1520.1520.210.21
Total Other Income Expenses Net -1.873-1.873-2.222-2.23-0.79-0.790.7290.729-2.235-2.235-3.893-3.893-4.147-4.147-10.247-10.247-5.313-5.313-8.381-8.381-5.651-5.651
Income Before Tax 14.04414.0449.669.6616.05216.05210.59510.59520.91620.91611.66411.66413.60813.6088.0188.0187.4097.40911.411.422.8422.84
Income Before Tax Ratio 0.0680.0680.050.050.0870.0870.060.060.1120.1120.0730.0730.0950.0950.0570.0570.0610.0610.0880.0880.1680.168
Income Tax Expense 3.9123.9122.562.563.8023.8022.1512.1514.6884.6883.1733.1733.593.593.6133.6130.7190.7193.563.565.7515.751
Net Income 10.02110.0217.0247.02412.13212.1328.3878.38716.08716.0878.3968.3969.9129.9124.2994.2996.6226.6227.7647.76416.91816.918
Net Income Ratio 0.0480.0480.0360.0360.0650.0650.0480.0480.0860.0860.0520.0520.0690.0690.0310.0310.0540.0540.060.060.1250.125
EPS 0.0180.0180.0120.0120.0210.0210.0140.0140.0270.0270.0140.0140.0170.0170.0070.0070.0150.0150.0170.0170.0380.038
EPS Diluted 0.0180.0180.0120.0120.0210.0210.0140.0140.0270.0270.0140.0140.0170.0170.0070.0070.0150.0150.0170.0170.0380.038
EBITDA 32.54232.54226.51626.51630.42730.42721.98521.98536.47636.47621.82321.82326.04326.04323.32423.32419.67319.67323.67723.67734.49734.497
EBITDA Ratio 0.1570.1570.1360.1360.1640.1640.1250.1250.1950.1950.1360.1360.1820.1820.1670.1670.1610.1610.1820.1820.2540.254